News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
14,110 Results
Type
Article (651)
Company Profile (3)
Press Release (13456)
Section
Business (3438)
Career Advice (5)
Deals (593)
Drug Delivery (1)
Drug Development (2144)
FDA (689)
Job Trends (287)
News (6688)
Policy (500)
Tag
Academia (30)
Adcomms (1)
Allergies (1)
Alliances (1033)
Alzheimer's disease (9)
Antibody-drug conjugate (ADC) (4)
Approvals (686)
Artificial intelligence (4)
Autoimmune disease (1)
Automation (2)
Bankruptcy (5)
Best Places to Work (256)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (11)
Brain cancer (4)
Breast cancer (1)
Cancer (86)
Cardiovascular disease (3)
Career advice (5)
CAR-T (1)
Cell therapy (3)
Clinical research (1639)
Collaboration (30)
Compensation (15)
COVID-19 (50)
C-suite (1)
Cystic fibrosis (1)
Data (69)
Diabetes (9)
Diagnostics (146)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (1)
Earnings (1462)
Events (2158)
Executive appointments (8)
FDA (729)
Frontotemporal dementia (1)
Funding (11)
Generative AI (1)
Gene therapy (6)
GLP-1 (18)
Government (71)
Grass and pollen (1)
Guidances (3)
Healthcare (514)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (1)
Indications (1)
Infectious disease (55)
Intellectual property (1)
IPO (249)
Job creations (35)
Job search strategy (5)
Layoffs (6)
Legal (62)
Liver cancer (1)
Lung cancer (15)
Lymphoma (4)
Machine learning (1)
Manufacturing (5)
MASH (7)
Medical device (714)
Medtech (714)
Mergers & acquisitions (353)
Metabolic disorders (18)
Multiple sclerosis (1)
NASH (1)
Neuroscience (14)
NextGen: Class of 2025 (137)
Non-profit (28)
Obesity (2)
Opinion (3)
Ovarian cancer (2)
Pain (6)
Pancreatic cancer (5)
Parkinson's disease (1)
Patents (8)
Patient recruitment (5)
People (798)
Pharmaceutical (2)
Phase I (780)
Phase II (804)
Phase III (391)
Pipeline (46)
Postmarket research (28)
Preclinical (331)
Press Release (2)
Prostate cancer (6)
Psychedelics (1)
Radiopharmaceuticals (29)
Rare diseases (7)
Real estate (70)
Regulatory (422)
Reports (1)
Research institute (50)
Resumes & cover letters (1)
RSV (5)
Series A (1)
Series B (2)
Special edition (1)
Spinal muscular atrophy (1)
Startups (78)
Supply chain (2)
Vaccines (18)
Date
Today (2)
Last 7 days (24)
Last 30 days (64)
Last 365 days (868)
2025 (260)
2024 (990)
2023 (1058)
2022 (1566)
2021 (1577)
2020 (1253)
2019 (882)
2018 (735)
2017 (705)
2016 (625)
2015 (747)
2014 (562)
2013 (464)
2012 (417)
2011 (496)
2010 (349)
Location
Africa (6)
Alabama (3)
Arizona (2)
Asia (1164)
Australia (178)
California (219)
Canada (30)
China (33)
Colorado (6)
Connecticut (5)
Delaware (7)
Europe (1658)
Florida (29)
Georgia (1)
Idaho (2)
Illinois (10)
Indiana (11)
Iowa (1)
Japan (1)
Louisiana (1)
Maine (1)
Maryland (24)
Massachusetts (130)
Michigan (1)
Minnesota (9)
Mississippi (1)
Montana (11)
Nevada (2)
New Jersey (38)
New Mexico (1)
New York (21)
North Carolina (14)
Northern California (129)
Ohio (1)
Pennsylvania (39)
Rhode Island (1)
South America (8)
Southern California (42)
Tennessee (1)
Texas (19)
United States (599)
Utah (1)
Virginia (2)
Washington State (3)
Wisconsin (4)
14,110 Results for "biomea fusion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biomea Fusion Announces Leadership Transition
March 26, 2025
·
3 min read
Press Releases
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
April 1, 2025
·
14 min read
Press Releases
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 1, 2025
April 2, 2025
·
1 min read
Press Releases
Biomea Fusion to Become a Diabetes & Obesity Medicines Company
January 14, 2025
·
8 min read
Press Releases
Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes
February 27, 2025
·
7 min read
Press Releases
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - March 3, 2025
March 4, 2025
·
1 min read
Press Releases
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
January 8, 2025
·
9 min read
Biotech Bay
Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
Biomea Fusion, Inc., announced that the Company has received notice from the U.S. Food and Drug Administration that a full clinical hold has been placed on Biomea’s ongoing Phase I/II clinical trials of the Company’s investigational covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes, respectively.
June 6, 2024
·
6 min read
Press Releases
Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Deals
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Biomea Fusion, Inc. today announced that on June 1, 2024, the compensation committee of Biomea’s board of directors granted one new employee non-qualified stock options to purchase an aggregate of 25,000 shares.
June 3, 2024
·
1 min read
1 of 1,411
Next
